This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ruperto, N. Articles by Martini, A. Search for Related Content PubMed PubMed Citation Articles by Ruperto, N. Articles by Martini, A. Pubmed/NCBI databases Medline Plus Health Information Lupus Social Bookmarking                         What's this?

Review: The Paediatric Rheumatology International Trials Organization (PRINTO)

IRCCS G Gaslini, Pediatria , Reumatologia, PRINTO, Genova, Italy, nicolaruperto{at}ospedale-gaslini.ge.it

A. Bazso

IRCCS G Gaslini, Pediatria , Reumatologia, PRINTO, Genova, Italy

A. Ravelli

IRCCS G. Gaslini, Pediatria , Reumatologia and Dipartimento di Pediatria, Università degli Studi, Genova, Italy

C. Malattia

IRCCS G Gaslini, Pediatria , Reumatologia, PRINTO, Genova, Italy

G. Filocamo

IRCCS G Gaslini, Pediatria , Reumatologia, PRINTO, Genova, Italy

A. Pistorio

IRCCS G Gaslini, Servizio di Epidemiologia e Biostatistica, Genova, Italy

A.L. Rodriguez Lozano

IRCCS G Gaslini, Pediatria , Reumatologia, PRINTO, Genova, Italy

S. Viola

IRCCS G Gaslini, Pediatria , Reumatologia, PRINTO, Genova, Italy

A. Martini

IRCCS G. Gaslini, Pediatria , Reumatologia and Dipartimento di Pediatria, Università degli Studi, Genova, Italy

In this review we describe an international project, conducted by the Paediatric Rheumatology International Trials Organization (PRINTO) that was aimed to identify, validate and promulgate core sets of measures and a definition of improvement for the evaluation of response to therapy in clinical trials and in daily clinical practice in patients with juvenile systemic lupus erythematosus (JSLE).

The following clinical measures were included in the PRINTO core set of outcome measure for the evaluation of response to therapy: 1) physician's global assessment of disease activity; 2) global disease activity measure; 3) 24-hour proteinuria; 4) parent's global assessment of the overall patient's well-being; 5) health-related quality of life assessment. The measures included in the core set were found to be feasible and not redundant, to have good construct validity, discriminative ability, internal consistency, with fair responsiveness to clinically important change in disease activity, and to be associated strongly with treatment outcome.

In order to be classified as responder to a given treatment, a patient should demonstrate at least 50% improvement from baseline in any two of the five core set measures with no more than one of the remaining worsening by more than 30%. This definition is now known as the `PRINTO/American College of Rheumatology (ACR) provisional criteria for JSLE'.

The proposed core set and definition of improvement incorporate clinically meaningful change in a composite endpoint for the evaluation of global response to therapy in JSLE. The definition is now proposed for use in JSLE clinical trials, and may help physicians to decide if a child with SLE has responded adequately to therapy. Lupus (2007) 16, 670—676.

Key Words: clinical trials • juvenile systemic lupus erythematosus • response to therapy

Lupus, Vol. 16, No. 8, 670-676 (2007)
DOI: 10.1177/0961203307079556


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				I E A Hoffman, B R Lauwerys, F De Keyser, T W J Huizinga, D Isenberg, L Cebecauer, J Dehoorne, R Joos, G Hendrickx, F Houssiau, et al. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus Ann Rheum Dis, March 1, 2009; 68(3): 412 - 415. [Abstract] [Full Text] [PDF]